NC
BIO icon

NewSquare Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

NewSquare Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3
Closed -$724 – 305
2025
Q2 		$724 Sell
3
-18
-86% -$4.25K ﹤0.01% 1093
2025
Q1 		$5.12K Buy
+21
New +$6.32K ﹤0.01% 694
2023
Q3 		– Sell
-5
Closed -$1.9K – 629
2023
Q2 		$1.9K Sell
5
-7
-58% -$2.85K ﹤0.01% 529
2023
Q1 		$5.75K Buy
12
+7
+140% +$3.28K ﹤0.01% 433
2022
Q4 		$2.1K Buy
5
+4
+400% +$1.61K ﹤0.01% 476
2022
Q3 		$0 Buy
+1
New +$499 ﹤0.01% 427

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NewSquare Capital's BIO Position: Q3 2025 in Review

NewSquare Capital sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 3 shares — an estimated $724 sold.

NewSquare Capital first reported a position in BIO in Q3 2022 and held it in 6 quarters. The position peaked at $5.75K in Q1 2023. 396 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • NewSquare Capital reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • NewSquare Capital sold 3 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $724.
  • NewSquare Capital first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 6 quarters.
  • NewSquare Capital's Bio-Rad Laboratories Class A position peaked at $5.75K in Q1 2023.
  • 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on NewSquare Capital's 13F filing for Q3 2025, filed 12 Nov 2025.